Published in Lancet Neurol on August 02, 2012
Carotid Revascularization Endarterectomy Versus Stenting Trial (CREST) | NCT00004732
Restenosis after carotid endarterectomy and stenting. Lancet Neurol (2012) 1.08
Systematic Review and Meta-Analysis of Carotid Artery Stenting Versus Endarterectomy for Carotid Stenosis: A Chronological and Worldwide Study. Medicine (Baltimore) (2015) 1.00
Carotid revascularization: risks and benefits. Vasc Health Risk Manag (2014) 0.87
Carotid artery stenting: review of technique and update of recent literature. Semin Intervent Radiol (2013) 0.85
Length of carotid stenosis predicts peri-procedural stroke or death and restenosis in patients randomized to endovascular treatment or endarterectomy. Int J Stroke (2013) 0.85
Acute reductions in mechanical wall strain precede the formation of intimal hyperplasia in a murine model of arterial occlusive disease. J Vasc Surg (2013) 0.83
Agreement between site-reported and ultrasound core laboratory results for duplex ultrasound velocity measurements in the Carotid Revascularization Endarterectomy versus Stenting Trial. J Vasc Surg (2013) 0.82
Effect of patching on reducing restenosis in the carotid revascularization endarterectomy versus stenting trial. Stroke (2015) 0.81
Carotid stenting versus endarterectomy in patients undergoing reintervention after prior carotid endarterectomy. J Vasc Surg (2013) 0.80
Age and gender disparities in the risk of carotid revascularization procedures. Neurol Sci (2013) 0.79
Carotid artery stenosis: cost-effectiveness of assessment of cerebrovascular reserve to guide treatment of asymptomatic patients. Radiology (2014) 0.79
Cost-Effectiveness of Carotid Plaque MR Imaging as a Stroke Risk Stratification Tool in Asymptomatic Carotid Artery Stenosis. Radiology (2015) 0.78
CT angiography after carotid artery stenting: assessment of the utility of adaptive statistical iterative reconstruction and model-based iterative reconstruction. Neuroradiology (2014) 0.78
Non-invasive imaging of carotid arterial restenosis using 3T cardiovascular magnetic resonance. J Cardiovasc Magn Reson (2014) 0.77
Long-term efficacy and safety of carotid artery stenting versus endarterectomy: A meta-analysis of randomized controlled trials. PLoS One (2017) 0.77
Restenosis after carotid endarterectomy and stenting--authors' reply. Lancet Neurol (2012) 0.76
Serum Levels of IL-1 β , IL-6, TGF- β , and MMP-9 in Patients Undergoing Carotid Artery Stenting and Regulation of MMP-9 in a New In Vitro Model of THP-1 Cells Activated by Stenting. Mediators Inflamm (2015) 0.76
Wall shear stress distribution at the carotid bifurcation: influence of eversion carotid endarterectomy. Eur Radiol (2013) 0.76
Prognostic Factors for Neurologic Outcome in Patients with Carotid Artery Stenting. Zhonghua Minguo Xin Zang Xue Hui Za Zhi (2016) 0.75
Clinical results of carotid artery stenting versus carotid endarterectomy. Neurosciences (Riyadh) (2016) 0.75
Anatomical and Technical Factors Influence the Rate of In-Stent Restenosis following Carotid Artery Stenting for the Treatment of Post-Carotid Endarterectomy Stenosis. PLoS One (2016) 0.75
Bilateral migration of open-cell design carotid stents in the early post-procedure period: a rare complication. Interv Neuroradiol (2014) 0.75
Restenosis after carotid artery stenting: remaining issues. Lancet Neurol (2012) 0.75
Carotid endarterectomy for treatment of carotid in-stent restenosis: long-term follow-up results and surgery experiences from one single centre. Stroke Vasc Neurol (2017) 0.75
In-stent restenosis after interventional treatment of carotid artery stenoses: a long-term follow-up of a single center cohort. Clin Res Cardiol (2017) 0.75
Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med (1991) 18.33
Stenting versus endarterectomy for treatment of carotid-artery stenosis. N Engl J Med (2010) 17.57
Endarterectomy for asymptomatic carotid artery stenosis. Executive Committee for the Asymptomatic Carotid Atherosclerosis Study. JAMA (1995) 15.80
Randomised trial of endarterectomy for recently symptomatic carotid stenosis: final results of the MRC European Carotid Surgery Trial (ECST) Lancet (1998) 10.64
Long-term results of carotid stenting versus endarterectomy in high-risk patients. N Engl J Med (2008) 4.72
Results of the Stent-Protected Angioplasty versus Carotid Endarterectomy (SPACE) study to treat symptomatic stenoses at 2 years: a multinational, prospective, randomised trial. Lancet Neurol (2008) 3.91
Stenting of Symptomatic Atherosclerotic Lesions in the Vertebral or Intracranial Arteries (SSYLVIA): study results. Stroke (2004) 3.90
Carotid artery stenosis: gray-scale and Doppler US diagnosis--Society of Radiologists in Ultrasound Consensus Conference. Radiology (2003) 3.59
Design of the Carotid Revascularization Endarterectomy vs. Stenting Trial (CREST). Int J Stroke (2010) 2.71
The Carotid Revascularization Endarterectomy versus Stenting Trial: credentialing of interventionalists and final results of lead-in phase. J Stroke Cerebrovasc Dis (2010) 2.35
Long-term risk of carotid restenosis in patients randomly assigned to endovascular treatment or endarterectomy in the Carotid and Vertebral Artery Transluminal Angioplasty Study (CAVATAS): long-term follow-up of a randomised trial. Lancet Neurol (2009) 2.32
Patterns of in-stent restenosis after carotid artery stenting: classification and implications for long-term outcome. J Vasc Surg (2007) 2.27
The influence of diabetes mellitus on acute and late clinical outcomes following coronary stent implantation. J Am Coll Cardiol (1998) 1.91
Restenosis is more frequent after carotid stenting than after endarterectomy: the EVA-3S study. Stroke (2011) 1.72
Optimal carotid duplex velocity criteria for defining the severity of carotid in-stent restenosis. J Vasc Surg (2008) 1.72
Duplex ultrasound velocity criteria for the stented carotid artery. J Vasc Surg (2008) 1.43
The Carotid Revascularization Endarterectomy vs. Stenting Trial completes randomization: lessons learned and anticipated results. J Vasc Surg (2009) 1.30
Carotid artery stenting: is there a need to revise ultrasound velocity criteria? J Vasc Surg (2004) 1.27
Recurrent carotid stenosis after carotid endarterectomy. Br J Surg (1997) 1.11
Ultrasound criteria for severe in-stent restenosis following carotid artery stenting. J Vasc Surg (2008) 1.08
Standardized ultrasound evaluation of carotid stenosis for clinical trials: University of Washington Ultrasound Reading Center. Cardiovasc Ultrasound (2010) 1.04
In-stent recurrent stenosis after carotid artery stenting: life table analysis and clinical relevance. J Vasc Surg (2003) 1.03
Grading carotid intrastent restenosis: a 6-year follow-up study. Stroke (2008) 1.00
Ultrasound velocity criteria for carotid in-stent restenosis. Catheter Cardiovasc Interv (2007) 0.99
Carotid restenosis: long-term noninvasive follow-up after carotid endarterectomy. Stroke (1988) 0.98
Restenosis after coronary stenting in current clinical practice. Am Heart J (1998) 0.96
Incidence of recurrent or residual stenosis after carotid endarterectomy. Am J Surg (1985) 0.87
Stenting versus endarterectomy for treatment of carotid-artery stenosis. N Engl J Med (2010) 17.57
Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature (2011) 13.25
Air pollution and cardiovascular disease: a statement for healthcare professionals from the Expert Panel on Population and Prevention Science of the American Heart Association. Circulation (2004) 13.07
The reasons for geographic and racial differences in stroke study: objectives and design. Neuroepidemiology (2005) 13.05
Stenting versus aggressive medical therapy for intracranial arterial stenosis. N Engl J Med (2011) 12.76
Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials. Lancet (2010) 12.21
Mechanical thrombectomy for acute ischemic stroke: final results of the Multi MERCI trial. Stroke (2008) 8.45
Safety and efficacy of mechanical embolectomy in acute ischemic stroke: results of the MERCI trial. Stroke (2005) 8.05
Trevo versus Merci retrievers for thrombectomy revascularisation of large vessel occlusions in acute ischaemic stroke (TREVO 2): a randomised trial. Lancet (2012) 7.89
Guidelines for the primary prevention of stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke (2010) 6.93
MRI profile and response to endovascular reperfusion after stroke (DEFUSE 2): a prospective cohort study. Lancet Neurol (2012) 5.91
Meta-analysis of multiple primary prevention trials of cardiovascular events using aspirin. Am J Cardiol (2011) 5.46
The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis. Lancet (2012) 4.87
Early-onset stroke and vasculopathy associated with mutations in ADA2. N Engl J Med (2014) 4.70
Primary central nervous system vasculitis: analysis of 101 patients. Ann Neurol (2007) 4.68
Disparities in stroke incidence contributing to disparities in stroke mortality. Ann Neurol (2011) 4.61
A randomized comparative effectiveness study of oral triple therapy versus etanercept plus methotrexate in early aggressive rheumatoid arthritis: the treatment of Early Aggressive Rheumatoid Arthritis Trial. Arthritis Rheum (2012) 4.01
Genetic risk factors for ischaemic stroke and its subtypes (the METASTROKE collaboration): a meta-analysis of genome-wide association studies. Lancet Neurol (2012) 3.93
Kidney function and cognitive impairment in US adults: the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study. Am J Kidney Dis (2008) 3.87
Long-Term Results of Stenting versus Endarterectomy for Carotid-Artery Stenosis. N Engl J Med (2016) 3.74
Sex differences in stroke: epidemiology, clinical presentation, medical care, and outcomes. Lancet Neurol (2008) 3.63
Statistical analysis of the primary outcome in acute stroke trials. Stroke (2012) 3.52
Guidelines for the primary prevention of stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke (2014) 3.48
Genome-wide association study identifies a variant in HDAC9 associated with large vessel ischemic stroke. Nat Genet (2012) 3.40
Percutaneous mitral repair with the MitraClip system: safety and midterm durability in the initial EVEREST (Endovascular Valve Edge-to-Edge REpair Study) cohort. J Am Coll Cardiol (2009) 3.26
Association of race and sex with risk of incident acute coronary heart disease events. JAMA (2012) 3.07
Incident cognitive impairment is elevated in the stroke belt: the REGARDS study. Ann Neurol (2011) 3.06
Genome-wide association analyses identify 18 new loci associated with serum urate concentrations. Nat Genet (2012) 3.04
A genome-wide genotyping study in patients with ischaemic stroke: initial analysis and data release. Lancet Neurol (2007) 2.99
Factors influencing the decline in stroke mortality: a statement from the American Heart Association/American Stroke Association. Stroke (2013) 2.88
Refractory hypertension: determination of prevalence, risk factors, and comorbidities in a large, population-based cohort. Hypertension (2013) 2.83
Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. J Am Coll Cardiol (2012) 2.78
Mutations in the colony stimulating factor 1 receptor (CSF1R) gene cause hereditary diffuse leukoencephalopathy with spheroids. Nat Genet (2011) 2.76
Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association. Circulation (2017) 2.76
Estimated 10-year stroke risk by region and race in the United States: geographic and racial differences in stroke risk. Ann Neurol (2008) 2.68
Paclitaxel-eluting stents show superiority to balloon angioplasty and bare metal stents in femoropopliteal disease: twelve-month Zilver PTX randomized study results. Circ Cardiovasc Interv (2011) 2.57
A simple, assumption-free, and clinically interpretable approach for analysis of modified Rankin outcomes. Stroke (2012) 2.57
Sequence variants on chromosome 9p21.3 confer risk for atherosclerotic stroke. Ann Neurol (2009) 2.55
Association of waist circumference and body mass index with all-cause mortality in CKD: The REGARDS (Reasons for Geographic and Racial Differences in Stroke) Study. Am J Kidney Dis (2011) 2.49
Chronic disease mortality in a cohort of smokeless tobacco users. Am J Epidemiol (2002) 2.43
The Secondary Prevention of Small Subcortical Strokes (SPS3) study. Int J Stroke (2011) 2.35
The Carotid Revascularization Endarterectomy versus Stenting Trial: credentialing of interventionalists and final results of lead-in phase. J Stroke Cerebrovasc Dis (2010) 2.35
Racial differences in the prevalence of chronic kidney disease among participants in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Cohort Study. J Am Soc Nephrol (2006) 2.32
High prevalence of stroke symptoms among persons without a diagnosis of stroke or transient ischemic attack in a general population: the REasons for Geographic And Racial Differences in Stroke (REGARDS) study. Arch Intern Med (2006) 2.32
Variants at APOE influence risk of deep and lobar intracerebral hemorrhage. Ann Neurol (2010) 2.31
A phase 3, randomized, double-blind comparative study of the efficacy and safety of topical recombinant human thrombin and bovine thrombin in surgical hemostasis. J Am Coll Surg (2007) 2.22
Whole genome analyses suggest ischemic stroke and heart disease share an association with polymorphisms on chromosome 9p21. Stroke (2008) 2.19
Differential gene expression in human abdominal aorta: aneurysmal versus occlusive disease. J Vasc Surg (2002) 2.17
Influence of sex on outcomes of stenting versus endarterectomy: a subgroup analysis of the Carotid Revascularization Endarterectomy versus Stenting Trial (CREST). Lancet Neurol (2011) 2.15
The HLA-DRB1 shared epitope is associated with susceptibility to rheumatoid arthritis in African Americans through European genetic admixture. Arthritis Rheum (2008) 2.13
Understanding the pathogenesis of abdominal aortic aneurysms. Expert Rev Cardiovasc Ther (2015) 2.08
Impact of angina class on inhibition of platelet aggregation following clopidogrel loading in patients undergoing coronary intervention: do we need more aggressive dosing regimens in unstable angina? Catheter Cardiovasc Interv (2003) 2.06
Implications of increased C-reactive protein for cardiovascular risk stratification in black and white men and women in the US. Clin Chem (2009) 2.03
Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. J Thorac Cardiovasc Surg (2012) 1.99
The Ischemic Stroke Genetics Study (ISGS) Protocol. BMC Neurol (2003) 1.98
2011 ASA/ACCF/AHA/AANN/AANS/ACR/ASNR/CNS/SAIP/SCAI/SIR/SNIS/SVM/SVS guideline on the management of patients with extracranial carotid and vertebral artery disease. Stroke (2011) 1.83
Receptor tyrosine kinase EphB4 is a survival factor in breast cancer. Am J Pathol (2006) 1.83
TREM2 in neurodegeneration: evidence for association of the p.R47H variant with frontotemporal dementia and Parkinson's disease. Mol Neurodegener (2013) 1.83
The Siblings With Ischemic Stroke Study (SWISS) protocol. BMC Med Genet (2002) 1.82
Relative edema volume is a predictor of outcome in patients with hyperacute spontaneous intracerebral hemorrhage. Stroke (2002) 1.82
Common variants at 6p21.1 are associated with large artery atherosclerotic stroke. Nat Genet (2012) 1.81
Genome-wide association study identifies a sequence variant within the DAB2IP gene conferring susceptibility to abdominal aortic aneurysm. Nat Genet (2010) 1.79
Anticoagulation after cardioembolic stroke: to bridge or not to bridge? Arch Neurol (2008) 1.79
Myocardial infarction after carotid stenting and endarterectomy: results from the carotid revascularization endarterectomy versus stenting trial. Circulation (2011) 1.78
Risk factors for progression of common carotid atherosclerosis: the Atherosclerosis Risk in Communities Study, 1987-1998. Am J Epidemiol (2002) 1.76
Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document (VARC-2). Eur J Cardiothorac Surg (2012) 1.74
NHANES monitoring of serum 25-hydroxyvitamin D: a roundtable summary. J Nutr (2010) 1.74
The IVH score: a novel tool for estimating intraventricular hemorrhage volume: clinical and research implications. Crit Care Med (2009) 1.73